Magnetic fluid accelerometer is designed based on the special physical properties of magnetic fluid. Compared with the conventional acceleration sensors, magnetic fluid accelerometer has stronger shock resistance capability, higher sensitivity, lower energy consumption, and better performance in low frequency response. It satisfies the growing requirements of acceleration sensors. In this paper, the dynamic model and the theory of magnetic fluid accelerometers were presented. The structure characteristics of typical magnetic fluid accelerometers were investigated, and the development trend of magnetic fluid accelerometers in the future was also predicted. Besides, a novel accelerometer with linearity better than 1.5% and sensitivity better than 75 mV/g was proposed.
Thermally recycleable zero-resistance states with transition temperatures above 200 K are observed in mixed-phase YBaCuO materials that are treated by a low-temperature (< 150° C ) oxygenation process and enclosed in an oxygen atmosphere during electrical and magnetic measurements. The zero-resistance state is verified through multiple lead and contact arrangements as well as by measurements of the current-voltage characteristics for several paths with the highest transition temperature (zero resistance) for any sample being 265 K and with a zero-voltage current exceeding 4.3 mA at 240 K. Although a full Meissner effect is not obtained, diamagnetic-like deviations and hysteretic behavior are observed to occur at the same temperatures as the resistive transitions. This indicates that the zero resistance, if related to superconductivity, is due to filamentary superconducting paths or materials of lower dimensionality.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.